Evidence for MedTech – the Swedish case of health technology assessment and a new tool to navigate it

Abstract Purpose Medical technology manufacturers and innovators have raised the need for more transparency on health technology assessment (HTA) and evidence requirements. The aim of this project was to develop and evaluate an evidence generation tool, a process map to support evidence generation in the context of Swedish HTA. This was facilitated by mapping the Swedish HTA system and processes. Methods The project undertook a mixed methods approach. Data collection and analysis was carried out to inform mapping of the HTA system and its processes, and evidence generation. A series of discussions were carried out with experts to refine the material. An expert workshop was organised to gather wider input on the current state of evidence generation for medical devices in Sweden. A proof-of-concept usability study was carried out to evaluate the evidence generation tool. The material was developed into a website. Results Here we present an analysis of the Swedish HTA system and processes, and hurdles for medical device evidence generation. A tool was developed, evaluated, and presented on a dedicated website to support evidence generation for medical devices in the context of Swedish HTA. Conclusions Evidence evaluation needs to be adapted for medical devices through wider and more informed collaboration between industry, assessors, patient representatives, and other stakeholder groups. This may increase the likelihood of more conclusive HTA. Further, improving the knowledge among companies and researchers on the HTA process may lead to more efficient clinical evidence generation. Further dissemination of the evidence generation tool may facilitate this.

Authors

Institutions

Publication Details

Journal
Health and Technology
Published
2025-01-01
DOI
https://doi.org/10.1007/s12553-024-00928-6
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evidence for MedTech – the Swedish case of health technology assessment and a new tool to navigate it

Adam S. Darwich, Malin Hollmark, Bertil Guve, Susanne Palmcrantz
Health and Technology
Health Systems, Economic Evaluations, Quality of Life
article

Evidence for MedTech – the Swedish case of health technology assessment and a new tool to navigate it

Adam S. Darwich, Malin Hollmark, Bertil Guve, Susanne Palmcrantz
article en

Abstract

Abstract Purpose Medical technology manufacturers and innovators have raised the need for more transparency on health technology assessment (HTA) and evidence requirements. The aim of this project was to develop and evaluate an evidence generation tool, a process map to support evidence generation in the context of Swedish HTA. This was facilitated by mapping the Swedish HTA system and processes. Methods The project undertook a mixed methods approach. Data collection and analysis was carried out to inform mapping of the HTA system and its processes, and evidence generation. A series of discussions were carried out with experts to refine the material. An expert workshop was organised to gather wider input on the current state of evidence generation for medical devices in Sweden. A proof-of-concept usability study was carried out to evaluate the evidence generation tool. The material was developed into a website. Results Here we present an analysis of the Swedish HTA system and processes, and hurdles for medical device evidence generation. A tool was developed, evaluated, and presented on a dedicated website to support evidence generation for medical devices in the context of Swedish HTA. Conclusions Evidence evaluation needs to be adapted for medical devices through wider and more informed collaboration between industry, assessors, patient representatives, and other stakeholder groups. This may increase the likelihood of more conclusive HTA. Further, improving the knowledge among companies and researchers on the HTA process may lead to more efficient clinical evidence generation. Further dissemination of the evidence generation tool may facilitate this.

Health and TechnologyVol. 15(1)
Karolinska Institutet (SE), Swedish Medtech (SE), KTH Royal Institute of Technology (SE)
VINNOVA, Kungliga Tekniska Högskolan
Industry, innovation and infrastructure
Openalex Percentile: Top 99%
Health Systems, Economic Evaluations, Quality of Life
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.